ADC Therapeutics America, Inc.

United States
ADC Therapeutics is a commercial-stage global leader and pioneer in the field of antibody-drug conjugates (ADCs). The company is dedicated to transforming the lives of those impacted by cancer by developing innovative treatments, such as ZYNLONTA, aimed at treating relapsed or refractory diffuse large B-cell lymphoma and other hematologic malignancies.

ADC Therapeutics America, Inc. Offices

Hybrid Workspace

Employees engage in a combination of remote and on-site work.

Typical time on-site: None
United States